← Leaderboards
Marilyn J Manco-Johnson
University Of Colorado Denver
$3,968,549
Attributed
$3,968,549
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $562K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
CDC$3,371,403 · 4
NIH$597,146 · 4
By mechanism
U01$3,120,123 · 3
U34$553,392 · 1
U18$251,280 · 1
M01$43,754 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Keith B Neeves$6,451,133
- Sandra L Martin$5,763,431
- Marian J. Rewers$53,889,410
- Beth Boulden Warren$911,756
- Tyler Wayne Buckner$843,015
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchPatient Oriented ResearchBlood Coagulation DisordersChildrenBlood CoagulationPainDiagnosis Design /EvaluationDisease /Disorder Prevention /ControlTrainingThrombosisAm 80Blood ClotBiomarkerAlteplaseAdverse EffectsBaseChildCentral Nervous System NeoplasmsApplications GrantsChildhoodAffectChronicCatheters
Grant awards (22)
Clinical Trial Planning Grant in Catheter-Directed Thrombolysis of Occlusive DVT$269,892
U34 · FY2013 · HL · contact PI
Patient-Level Meta-analysis: Effect of age of initiation, intensity and duration$189,998
U01 · FY2013 · DD · contact PI
Clinical Trial Planning Grant in Catheter-Directed Thrombolysis of Occlusive DVT$283,500
U34 · FY2012 · HL · contact PI
Patient-Level Meta-analysis: Effect of age of initiation, intensity and duration$200,000
U01 · FY2012 · DD · contact PI
Patient-Level Meta-analysis: Effect of age of initiation, intensity and duration$200,000
U01 · FY2011 · DD · contact PI
Models of Care and Research in Thrombosis and Thrombophilia$175,000
U01 · FY2011 · DD · contact PI
Prevention of Complications in Hemophilia Through HTCs$241,117
U01 · FY2010 · DD · contact PI
Models of Care and Research in Thrombosis and Thrombophilia$200,000
U01 · FY2010 · DD · contact PI
Prevention of Complications in Hemophilia Through HTCs$282,008
U01 · FY2009 · DD · contact PI
Models of Care and Research in Thrombosis and Thrombophilia$280,000
U01 · FY2009 · DD · contact PI
Prevention of Complications in Hemophilia Through HTCs$282,000
U01 · FY2008 · DD · contact PI
Models of Care and Research in Thrombosis and Thrombophilia$220,000
U01 · FY2008 · DD · contact PI
Prevention of Complications in Hemophilia Through HTCs$300,000
U01 · FY2007 · DD · contact PI
Models of Care and Research in Thrombosis and Thrombophilia$250,000
U01 · FY2007 · DD · contact PI
Prevention of Complications in Hemophilia Through HTCs$300,000
U01 · FY2006 · DD · contact PI
Integrating Prevention Services for Bleeding & Clottiing$251,280
U18 · FY2006 · DD · contact PI
CANCER PROCOAGULANT IN PED PTS W/SARCOMAS &CNS TUMORS$538
M01 · FY2005 · RR
Integrating Prevention Services for Bleeding &Clottiing$0
U18 · FY2005 · DD
Cancer Procoagulant in Ped. Pts. w/Sarcomas &CNS Tumors$19,120
M01 · FY2004 · RR
Standardization of New Coagulation Assays$16,641
M01 · FY2004 · RR
Outcome Measures for Post-Thrombotic Syndrome$7,455
M01 · FY2004 · RR
Integrating Prevention Services for Bleeding &Clottiing$0
U18 · FY2004 · DD